Neuland Laboratories Limited
NEULANDLAB.NS

$2.27 B
Marketcap
$176.89
Share price
Country
$1.62
Change (1 day)
$196.21
Year High
$58.36
Year Low

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.

marketcap

Neuland Laboratories Limited (NEULANDLAB.NS) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2023 44.55 M -2,536,110 65.15 M 217.12 M 109.13 M
2022 43.68 M 9.84 M 69.39 M 187.17 M 90.15 M
2021 28.19 M 27.89 M 64.33 M 163.91 M 69.05 M
2020 26.14 M 21.31 M 63.78 M 156.96 M 65.11 M
2019 22.75 M 29.92 M 61.73 M 145.84 M 61.04 M